Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$59.26 - $71.14 $232,536 - $279,153
-3,924 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$55.72 - $67.12 $780 - $939
14 Added 0.36%
3,924 $260,000
Q4 2021

Feb 07, 2022

SELL
$54.02 - $63.83 $37,381 - $44,170
-692 Reduced 15.04%
3,910 $227,000
Q3 2021

Oct 29, 2021

BUY
$55.56 - $60.79 $2,833 - $3,100
51 Added 1.12%
4,602 $276,000
Q2 2021

Jul 20, 2021

SELL
$48.42 - $60.18 $38,493 - $47,843
-795 Reduced 14.87%
4,551 $273,000
Q1 2021

May 03, 2021

SELL
$47.16 - $54.44 $18,015 - $20,796
-382 Reduced 6.67%
5,346 $265,000
Q4 2020

Feb 02, 2021

SELL
$48.52 - $58.02 $4,852 - $5,802
-100 Reduced 1.72%
5,728 $289,000
Q3 2020

Oct 13, 2020

SELL
$53.07 - $61.1 $53 - $61
-1 Reduced 0.02%
5,828 $319,000
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $99,388 - $127,544
-2,306 Reduced 28.35%
5,829 $308,000
Q1 2020

May 05, 2020

BUY
$37.79 - $51.33 $307,421 - $417,569
8,135 New
8,135 $363,000
Q1 2020

May 01, 2020

SELL
$37.79 - $51.33 $320,572 - $435,432
-8,483 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$40.12 - $45.47 $1,484 - $1,682
-37 Reduced 0.43%
8,483 $378,000
Q2 2019

Jul 31, 2019

SELL
$37.28 - $41.68 $11,444 - $12,795
-307 Reduced 3.48%
8,520 $351,000
Q1 2019

Apr 25, 2019

BUY
$35.49 - $43.02 $2,448 - $2,968
69 Added 0.79%
8,827 $357,000
Q4 2018

Jan 10, 2019

BUY
$36.86 - $41.49 $1,879 - $2,115
51 Added 0.59%
8,758 $332,000
Q3 2018

Nov 08, 2018

SELL
$34.76 - $39.72 $3,719 - $4,250
-107 Reduced 1.21%
8,707 $345,000
Q1 2018

Apr 20, 2018

BUY
$32.97 - $36.63 $3,626 - $4,029
110 Added 1.26%
8,814 $308,000
Q3 2017

Oct 24, 2017

BUY
$28.96 - $34.0 $2,548 - $2,992
88 Added 1.02%
8,704 $295,000
Q2 2017

Sep 18, 2017

BUY
N/A
8,616
8,616 $250,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Mps Loria Financial Planners, LLC Portfolio

Follow Mps Loria Financial Planners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mps Loria Financial Planners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mps Loria Financial Planners, LLC with notifications on news.